INNOCAN PHARMA CORP
INNOCAN PHARMA CORP
Share · CA45783P1027 · A2PSPW (XTSE)
Overview
No Price
18.03.2026 19:50
Current Prices from INNOCAN PHARMA CORP
ExchangeTickerCurrencyLast TradePriceDaily Change
XCNQ: CSE LISTED
CSE LISTED
INNO.CN
CAD
18.03.2026 17:46
6,61 CAD
0,37 CAD
+5,93 %
OTC: UTC
UTC
INNPF
USD
18.03.2026 17:46
4,76 USD
-12,61 USD
-72,60 %
Share Float & Liquidity
Free Float 79,59 %
Shares Float 3,58 M
Shares Outstanding 4,5 M
Company Profile for INNOCAN PHARMA CORP Share
InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Poland, France, and internationally. The company engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes. Its product includes CBD eye serum, CBD face oil, CBD face cream, CBD facial serum, CBD sleeping mask, CBD recovery lotion, and the Relief & Go spray. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products. InnoCan Pharma Corporation was incorporated in 2018 and is headquartered in Calgary, Canada.
AI Analysis of INNOCAN PHARMA CORP
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of INNOCAN PHARMA CORP
No AI threads available for this company yet.

Company Data

Name INNOCAN PHARMA CORP
Company INNOCAN PHARMA Corp
Website https://innocanpharma.com
Primary Exchange XTSE TSX
WKN A2PSPW
ISIN CA45783P1027
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Iris Bincovich
Market Capitalization 41 Mio
Country Canada
Currency CAD
Employees 0,0 T
Address 1015, 926 – 5 Avenue SW, T2P 0N7 Calgary
IPO Date 2020-11-27
Dividends from 'INNOCAN PHARMA CORP'
Ex-Date Dividend per Share
13.02.2026 0,37 USD
14.11.2025 0,37 USD
16.05.2025 0,37 USD
14.02.2025 0,37 USD
16.08.2024 0,37 USD
16.05.2024 0,37 USD
14.02.2024 0,37 USD
15.11.2023 0,37 USD
16.08.2023 0,37 USD
16.05.2023 0,37 USD

Stock Splits

Date Split
05.09.2025 1:65

Ticker Symbols

Name Symbol
Over The Counter INNPF
CSE LISTED INNO.CN
Frankfurt IP4.F
More Shares
Investors who hold INNOCAN PHARMA CORP also have the following shares in their portfolio:
ADOBE INC
ADOBE INC Share
ALLIANZ AG
ALLIANZ AG Share
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Share
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
BRITISH TELECOMMUNICATIONS PLC 3.924% NTS 25/06/42
BRITISH TELECOMMUNICATIONS PLC 3.924% NTS 25/06/42 Bond
FRESENIUS SE
FRESENIUS SE Share
LB.HESS.THR.CARRARA07A/17
LB.HESS.THR.CARRARA07A/17 Bond
LYXOR NASDAQ-100 DAILY (2X) LEVERAGED UCITS ETF - ACC
LYXOR NASDAQ-100 DAILY (2X) LEVERAGED UCITS ETF - ACC ETF
META PLATFORMS INC
META PLATFORMS INC Share
MICROSOFT CORP
MICROSOFT CORP Share
PALANTIR TECHNOLOGIESLOGIES INC CLASS A
PALANTIR TECHNOLOGIESLOGIES INC CLASS A Share
PAYPAL INC
PAYPAL INC Share
RIO TINTO
RIO TINTO Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026